Atlas Trials

Evaluation Of CanADVICE+®M-Health System To Support Breast Cancer Patients Receiving Capecitabine

Clinical trial NCT02580396 · COMPLETED

Trial details

NCT number
NCT02580396
Sponsor
Royal Marsden NHS Foundation Trust
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2016-03-16
Primary completion
2018-11-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.